Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Zur Rose Group AG
  6. News
  7. Summary
    ROSE   CH0042615283

ZUR ROSE GROUP AG

(ROSE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ZUR ROSE GROUP : Baader Bank reaffirms its Buy rating

04/30/2021 | 06:22am EDT

In a research note published by Volker Bosse, Baader Bank advises its customers to buy the stock. The target price remains unchanged at CHF 500.


© MarketScreener with dpa-AFX Analyser 2021
All news about ZUR ROSE GROUP AG
05/07STOXX EUROPE 600  : European Commission Approves Acquisition Of Joint Control Of..
MT
05/06ZUR ROSE GROUP  : Jefferies reiterates its Buy rating
MD
04/30ZUR ROSE GROUP  : Baader Bank reaffirms its Buy rating
MD
04/29ANNUAL GENERAL MEETING OF ZUR ROSE G : Shareholders approve all proposals
PU
04/29ANNUAL GENERAL MEETING OF ZUR ROSE G : Shareholders approve all proposals
EQ
04/28DOCMORRIS EXPANDS MANAGEMENT TEAM : Dr. Ulrich Thomé is appointed Chief Strategy..
PU
04/27ZUR ROSE GROUP  : UBS reaffirms its Sell rating
MD
04/22ZUR ROSE GROUP  : Receives a Buy rating from Berenberg
MD
04/21ZUR ROSE GROUP  : Sell rating from UBS
MD
04/20Global markets live: BMW, IBM, Credit Suisse…
More news
Financials
Sales 2021 1 805 M 2 004 M 2 004 M
Net income 2021 -111 M -123 M -123 M
Net Debt 2021 357 M 396 M 396 M
P/E ratio 2021 -30,2x
Yield 2021 -
Capitalization 2 891 M 3 204 M 3 209 M
EV / Sales 2021 1,80x
EV / Sales 2022 1,27x
Nbr of Employees 1 960
Free-Float 88,5%
Chart ZUR ROSE GROUP AG
Duration : Period :
Zur Rose Group AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZUR ROSE GROUP AG
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Average target price 458,36 CHF
Last Close Price 302,00 CHF
Spread / Highest target 98,7%
Spread / Average Target 51,8%
Spread / Lowest Target -14,9%
EPS Revisions
Managers and Directors
NameTitle
Walter Oberhänsli Chief Executive Officer & Executive Director
Marcel Ziwica Chief Financial Officer
Stefan Feuerstein Chairman
Bernd Michael Gschaider Chief Operating Officer
Thomas Schneider Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
ZUR ROSE GROUP AG6.71%3 204
JD HEALTH INTERNATIONAL INC.-23.13%47 274
WALGREENS BOOTS ALLIANCE, INC.36.56%47 135
MCKESSON CORPORATION13.62%31 222
CARDINAL HEALTH, INC.5.56%17 080
HUADONG MEDICINE CO., LTD64.08%11 854